OpenVSafe by OpenVAERS
Search V-safe

AMX-24265-41795

2 vaccinations 2 coded responses 25 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
598 / MT
Registered
2021-01-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-22
    Registered in v-safe
  2. 2021-01-22
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-22
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  5. 2021-01-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  7. 2021-01-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  8. 2021-01-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  9. 2021-01-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-29
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-02-05
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-02-12
    Dose 2 — Pfizer-BioNTech
  13. 2021-02-12
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  14. 2021-02-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness — Feeling: Poor · Site: Pain · Fever · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-02-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  16. 2021-02-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  17. 2021-02-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-02-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  20. 2021-02-19
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-02-26
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-05
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-13
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-19
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-03-26
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-05-15
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-08-13
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2022-02-12
    Survey response — 12 months, dose 2
    MedDRA: Abortion spontaneous, Cough, Fatigue, SARS-CoV-2 test positive, Sinus congestion, Surgery, Ultrasound foetal abnormal, Uterine dilation and curettage — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: contracted COVID and tested positive 1/12/22, mild symptoms - cough, sinus congestion, and fatigue, had likely unrelated 1st trimester miscarriage at 9 weeks noted on ultrasound 1/24/22, embryo growth measured 8 weeks, no HR, D&C surgery 1/26/22 · Healthcare visit (other): Outpatient surgery
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-02-12
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  30. 2022-02-16

Vaccinations

DoseDateManufacturerCo-administered
12021-01-22Pfizer-BioNTech
22021-02-12Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2022-02-12 Unsuccessful

Free text

Release 4 — days 1–6 daily, dose 2

2021-02-13

Systemic reaction (other): Dizziness

Release 11 — 12 months, dose 2

2022-02-12

Symptoms: contracted COVID and tested positive 1/12/22, mild symptoms - cough, sinus congestion, and fatigue, had likely unrelated 1st trimester miscarriage at 9 weeks noted on ultrasound 1/24/22, embryo growth measured 8 weeks, no HR, D&C surgery 1/26/22
Healthcare visit (other): Outpatient surgery

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOSurgery · · ✓
SDAbortion spontaneous · · ✓
SDCough · · ✓
SDFatigue · · ✓
SDSARS-CoV-2 test positive · · ✓
SDSinus congestion · · ✓
SDUltrasound foetal abnormal · · ✓
SDUterine dilation and curettage · · ✓
SRODizziness ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release